Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity
Author | Faezeh Najafzadeh | en |
Author | Reza Shapouri | en |
Author | Mehdi Rahnema | en |
Author | Shadi Rokhsartalab Azar | en |
Author | Anvarsadat Kianmehr | en |
Issued Date | 2015-06-01 | en |
Abstract | Background: Treatment of Pseudomonas aeruginosa PAO-1 infections through immunological means has been proved to be efficient and protective. Objectives: The purpose of this study was to produce a conjugate vaccine composed of detoxified lipopolysaccharide (D-LPS) P. aeruginosa and diphtheria toxoid (DT). Materials and Methods: Firstly, LPS was purified and characterized from P. aeruginosa PAO1 and then detoxified. D-LPS was covalently coupled to DT as a carrier protein via amidation method with adipic acid dihydrazide (ADH) as a spacer molecule and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide (EDAC) as a linker. The molar ratio of LPS to DT in the prepared conjugate was 3:1. The immunogenicity of D-LPS-DT conjugate vaccine in mice model was evaluated as well. Results: The conjugate was devoid of endotoxin activity and 0.125 U/mL of D-LPS was acceptable for immunization. D-LPS-DT conjugate was nonpyrogenic for rabbits and nontoxic for mice. Mice immunization with D-LPS-DT conjugate vaccine elicited the fourfold higher IgG antibody compared to D-LPS. Anti-LPS IgG antibody was predominantly IgG1 subclass and then IgG3, IgG2a and IgG2b, respectively. Conclusions: Vaccine based on the conjugation of P. aeruginosa PAO-1 LPS with DT increased anti-LPS antibodies and had a significant potential to protect against Pseudomonas infections. | en |
DOI | https://doi.org/10.5812/jjm.8(5)2015.17712 | en |
Keyword | <i>Pseudomonas aeruginosa</i> PAO-1 | en |
Keyword | Vaccines | en |
Keyword | Conjugate | en |
Keyword | Lipopolysaccharides | en |
Keyword | Diphtheria Toxoid | en |
Publisher | Brieflands | en |
Title | Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 56403-pdf.pdf
- Size:
- 395.82 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF